KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Net Debt Issuances and Repayments: 2009-2010

Historic Net Debt Issuances and Repayments for Jazz Pharmaceuticals (JAZZ) over the last 2 years, with Dec 2010 value amounting to $19.7 million.

  • Jazz Pharmaceuticals' Net Debt Issuances and Repayments was N/A to $28.0 million in Q1 2011 from the same period last year, while for Mar 2011 it was $69.5 million, marking a year-over-year change of. This contributed to the annual value of $19.7 million for FY2010, which is 87.67% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Net Debt Issuances and Repayments of $19.7 million as of FY2010, which was up 87.67% from $10.5 million recorded in FY2009.
  • Jazz Pharmaceuticals' 5-year Net Debt Issuances and Repayments high stood at $19.7 million for FY2010, and its period low was $10.5 million during FY2009.
  • In the last 2 years, Jazz Pharmaceuticals' Net Debt Issuances and Repayments had a median value of $15.1 million in 2009 and averaged $15.1 million.
  • Data for Jazz Pharmaceuticals' Net Debt Issuances and Repayments shows a peak YoY surged of 87.67% (in 2010) over the last 5 years.
  • Jazz Pharmaceuticals' Net Debt Issuances and Repayments (Yearly) stood at $10.5 million in 2009, then surged by 87.67% to $19.7 million in 2010.